FALMOUTH, Mass., March 18, 2014 /PRNewswire/ — Associates of Cape Cod, Inc. (ACC) is pleased to introduce a new, FDA licensed version of our rapid endotoxin detection kit, Pyrosate. Pyrosate is well suited for performing endotoxin assays in full compliance with the Bacterial Endotoxins Test, USP chapter <85>. Pyrosate has been developed as an easy-to-use Limulus Amebocyte Lysate (LAL) gel-clot test that enables rapid testing and does not require special laboratory supplies. The easy to follow, step-by-step illustrated instructions allow the user to set up assays within minutes.

In addition to FDA licensure, the Pyrosate Kit is now available in sensitivities of 0.03 EU/mL, 0.125 EU/mL and 0.25 EU/mL, in both 10 pack and 30 pack formats. With the introduction of this licensed version, in addition to research and water testing, Pyrosate is ideal for dialysis centers, compounding pharmacies, pharmaceutical and medical device companies.

Dr. AJ Meuse, President and CEO, said, “ACC is the pioneer in endotoxin detection and the first company licensed by the FDA to manufacture LAL for use as a quality control test. We are constantly looking at new approaches to improve existing product offerings and introduce innovative new products. We are quite proud to introduce the newly FDA licensed Pyrosate Kit.”

ACC is an industry innovator and has been a leading global supplier of endotoxin and glucan detection products and services for 40 years. During this time, ACC has supplied our customers with products and services that have helped ensure the safety of their parenteral drugs, biological products and medical devices.

For more information on ACC’s licensed Pyrosate Rapid Endotoxin Detection Kit, contact Associates of Cape Cod, Inc. at 124 Bernard E. Saint Jean Drive, E. Falmouth, MA 02536, 508-540-3444, www.acciusa.com.

Photo – http://photos.prnewswire.com/prnh/20140318/NE85632

SOURCE Associates of Cape Cod, Inc.